Quantum Biopharma Ltd
(QNTM)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Operating Expenses | 6,119 | 5,133 | 12,689 | 9,803 | 6,022 |
| Operating Income | -6,119 | -5,133 | -12,689 | -9,803 | -6,022 |
| Interest Expense | 29 | 2 | 19 | 19 | 33 |
| Other Income | -15 | -480 | -46 | 416 | 2,091 |
| Pre-tax Income | -6,163 | -5,615 | -12,754 | -9,406 | -3,964 |
| Net Income Continuous | -6,163 | -5,615 | -12,754 | -9,406 | -3,964 |
| Net Income Discontinuous | -185 | -176 | -453 | -534 | -414 |
| Net Income | $-6,348 | $-5,791 | $-13,207 | $-9,940 | $-4,378 |
| EPS Basic Total Ops | -8.44 | -9.74 | -23.38 | -24.03 | 4.55 |
| EPS Basic Continuous Ops | -7.30 | -10.05 | -23.01 | -22.71 | 3.30 |
| EPS Basic Discontinuous Ops | -0.08 | -0.32 | -0.82 | -1.29 | 1.56 |
| EPS Diluted Total Ops | -8.44 | -9.74 | -23.38 | -24.03 | 4.55 |
| EPS Diluted Continuous Ops | -7.30 | -10.05 | -23.01 | -22.71 | 3.30 |
| EPS Diluted Discontinuous Ops | -0.08 | -0.32 | -0.82 | -1.29 | 1.56 |
| EBITDA(a) | $-5,012 | $-4,128 | $-11,707 | $-8,852 | $-5,054 |